| ID | Assay | Related subunit | Celltype | Tissue | Disease | Treatment1 | Treatment2 | Study | Download1 | Download2 |
|---|---|---|---|---|---|---|---|---|---|---|
| CDBD00899 | ChIPseq | Rad21 | Hep-G2 | Liver | Cancer | NT | NT | GSE72082 | ||
| CDBD00898 | ChIPseq | Rad21 | Hep-G2 | Liver | Cancer | NT | NT | GSE72082 | ||
| CDBD00897 | ChIPseq | Rad21 | Hep-G2 | Liver | Cancer | CRISPR | NT | GSE72082 | ||
| CDBD00896 | ChIPseq | Rad21 | Hep-G2 | Liver | Cancer | CRISPR | NT | GSE72082 | ||
| CDBD00895 | ChIPseq | Rad21 | Hep-G2 | Liver | Cancer | CRISPR | NT | GSE72082 | ||
| CDBD00699 | ChIPseq | Rad21 | Hep-G2 | Liver | Cancer | NT | NT | GSE25021 | ||
| CDBD00698 | ChIPseq | Rad21 | Hep-G2 | Liver | Cancer | NT | NT | GSE25021 | ||
| CDBD00197 | ChIPseq | Rad21 | Hep-G2 | Liver | Cancer | NT | CRISPR-Rad21 | ENCSR338DUC | ||
| CDBD00196 | ChIPseq | Rad21 | Hep-G2 | Liver | Cancer | NT | CRISPR-Rad21 | ENCSR338DUC | ||
| CDBD00166 | ChIPseq | Rad21 | Hep-G2 | Liver | Cancer | NT | CRISPR-Rad21 | ENCSR054FKH | ||
| CDBD00153 | ChIPseq | Rad21 | Hep-G2 | Liver | Cancer | NT | NT | ENCSR000EEG | ||
| CDBD00152 | ChIPseq | Rad21 | Hep-G2 | Liver | Cancer | NT | NT | ENCSR000EEG | ||
| CDBD00125 | ChIPseq | Rad21 | Hep-G2 | Liver | Cancer | NT | NT | ENCSR000BLS | ||
| CDBD00124 | ChIPseq | Rad21 | Hep-G2 | Liver | Cancer | NT | NT | ENCSR000BLS | ||
| CDBD00044 | ChIAPET | Rad21 | Hepatocyte-H9 | Liver | Normal | NT | NT | ENCSR381DCY | ||
| CDBD00043 | ChIAPET | Rad21 | Hepatocyte-H9 | Liver | Normal | NT | NT | ENCSR381DCY | ||
| CDBD00019 | ChIAPET | Rad21 | Hep-G2 | Liver | Cancer | NT | NT | ENCSR146FPM | ||
| CDBD00018 | ChIAPET | Rad21 | Hep-G2 | Liver | Cancer | NT | NT | ENCSR146FPM |